Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Oezkan Yalkinoglu"'
Autor:
Wilhelmina Maria Bagchus, Deon Bezuidenhout, Eleanor Harrison‐Moench, Elly Kourany‐Lefoll, Peter Wolna, Oezkan Yalkinoglu
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 1, Pp 66-76 (2019)
Orally dispersible tablet (ODT) formulations of levo praziquantel (L‐PZQ) and racemic PZQ (rac‐PZQ) are being developed to treat schistosomiasis in preschool‐aged children. Two crossover studies (N = 32 and 36, respectively) assessed the relati
Externí odkaz:
https://doaj.org/article/936d038baeca4aaf9835448040d0e918
Publikováno v:
Clinical Pharmacology and Therapeutics
Clinical Pharmacology & Therapeutics
Clinical Pharmacology & Therapeutics
The unprecedented challenges posed by the coronavirus disease 2019 (COVID‐19) pandemic highlight the urgency for applying clinical pharmacology and model‐informed drug development in (i) dosage optimization for COVID‐19 therapies, (ii) approach
Autor:
Eleanor Harrison-Moench, Peter Wolna, Oezkan Yalkinoglu, Wilhelmina Bagchus, Elly Kourany-Lefoll, Deon Bezuidenhout
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 1, Pp 66-76 (2019)
Clinical and Translational Science
Clinical and Translational Science
Orally dispersible tablet (ODT) formulations of levo praziquantel (L‐PZQ) and racemic PZQ (rac‐PZQ) are being developed to treat schistosomiasis in preschool‐aged children. Two crossover studies (N = 32 and 36, respectively) assessed the relati